Latest filing published 15 Aug 2006 for CHAD THERAPEUTICS INC, €2,386.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Earl L. Yager: trading record in brief
All filings by Earl L. Yager on record concern Chad Therapeutics Inc. In total, 5 filings cover trades dated from 30 April 2006 to 15 August 2006.
Purchases make up the whole of the open-market record (5 purchases, €21k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €2,344.
Most recently, on 15 August 2006, the filings show an open-market purchase worth €2,386 in Chad Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 46 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Earl L. Yager
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 994 shares@ US$3.02Common SharesSEC:0001209191-06-045903:0Canonical exit: 29 Jul 2006 (T+90)
- 1,099 shares@ US$2.73Common SharesSEC:0001209191-06-045903:1Canonical exit: 29 Aug 2006 (T+90)
- 1,070 shares@ US$2.80Common SharesSEC:0001209191-06-045903:2Canonical exit: 28 Sept 2006 (T+90)
- 1,134 shares@ US$2.65Common SharesSEC:0001209191-06-045903:3Canonical exit: 29 Oct 2006 (T+90)
- 10,000 shares@ US$1.53Common SharesSEC:0001209191-06-045903:4Canonical exit: 13 Nov 2006 (T+90)
5 of 5 declarations